John M. Evans

Newest6Bought0Sold6Include share awards4

Company	Trade	Date	Stock since trade
Beam TherapeuticsBEAM	Sold $599.6K · 25,000 shares	Oct 16, 2026	+22.9%S&P 500 +1.2%thru Oct 29
Beam TherapeuticsBEAM	Sold $589.1K · 25,000 shares	Oct 15, 2026	+16.6%S&P 500 +0.1%thru Oct 29
Beam TherapeuticsBEAM	Sold $66.2K · 1,900 shares	Jun 30, 2026	−16.0%S&P 500 +3.4%thru Oct 29
Beam TherapeuticsBEAM	Sold $791.5K · 23,100 shares	Jun 30, 2026	−16.0%S&P 500 +3.4%thru Oct 29
Beam TherapeuticsBEAM	Sold $415.8K · 11,579 shares	Jun 29, 2026	−17.5%S&P 500 +4.2%thru Oct 29
Beam TherapeuticsBEAM	Sold $471.5K · 13,421 shares	Jun 29, 2026	−17.5%S&P 500 +4.2%thru Oct 29

SoldBeam Therapeutics

Oct 16, 2026 · BEAM

$599.6K

+22.9%S&P 500 +1.2%thru Oct 29

SoldBeam Therapeutics

Oct 15, 2026 · BEAM

$589.1K

+16.6%S&P 500 +0.1%thru Oct 29

SoldBeam Therapeutics

Jun 30, 2026 · BEAM

$66.2K

−16.0%S&P 500 +3.4%thru Oct 29

SoldBeam Therapeutics

Jun 30, 2026 · BEAM

$791.5K

−16.0%S&P 500 +3.4%thru Oct 29

SoldBeam Therapeutics

Jun 29, 2026 · BEAM

$415.8K

−17.5%S&P 500 +4.2%thru Oct 29

SoldBeam Therapeutics

Jun 29, 2026 · BEAM

$471.5K

−17.5%S&P 500 +4.2%thru Oct 29

Newest 10 of 22 transactions ·Pro adds every trade with how it did, their holdings and the money-flow chart ·Pro is $29 a month →